General
Novo Nordisk names new CEO amid share price slump and concerns over Wegovy, Ozempic sales
Danish pharmaceutical giant Novo Nordisk, known for its weight-loss drugs Wegovy and Ozempic, has named Maziar Mike Doustdar as its new chief executive, relying on an experienced company insider to make up ground lost to market rivals.
Mr Doustdar’s appointment came on Tuesday after the abrupt…
Continue Reading
-
Noosa News18 hours agoNRL grand final quick hits: Reece Walsh creates magic after avoiding sin bin as Broncos survive Hunt, Reynolds injuries to win premiership
-
General17 hours agoHow the internet reacted to Brisbane Broncos winning the NRL grand final
-
Noosa News9 hours agoNew playground equipment encourages children to learn through ‘risky play’
-
General6 hours agoThree youths in police custody after fire at Ashley Youth Detention Centre in northern Tasmania